COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1196: Articles 11951-11960  | Next

Intronization enhances expression of S-protein and other transgenes challenged by cryptic splicing
Tomberg, K., Antunes, L., Pan, Y., Hepkema, J., Garyfallos, D. A., Mahfouz, A., Bradley, A.
10.1101/2021.09.15.460454 — Posted: 2021-09-15
Molecular architecture of SARS-CoV-2 envelope by integrative modeling
Pezeshkian, W., Grunewald, F., Narykov, O., Lu, S., Wassenaar, T., Marrink, S.-J. J., Korkin, D.
10.1101/2021.09.15.459697 — Posted: 2021-09-15
Phylodynamic Pattern of Genetic Clusters, Paradigm Shift on Spatio-temporal Distribution of Clades, and Impact of Spike Glycoprotein Mutations of SARS-CoV-2 Isolates from India
Subramanian, S., Kitambi, S.
10.1101/2021.09.15.460506 — Posted: 2021-09-15
Interrogating COVID-19 Vaccine Hesitancy in the Philippines with a Nationwide Open-Access Online Survey
Caple, A., Dimaano, A., Sagolili, M. M., Uy, A. A., Aguirre, P. M., Alano, D. L., Camaya, G. S., Ciriaco, B. J., Clavo, P. J., Cuyugan, D., Fermo, C. F. G., Lanete, P. J., La Torre, A. J., Loteyro, T. A., Lua, R. M., Manansala, N. G., Mosquito, R. W., Octaviano, A. M., Orfanel, A. E., Pascual, G. M., Sale, A. J., Tendenilla, S. L., Trinidad, M. S., Trinidad, N. J., Verano, D. L., Austriaco, N.
10.1101/2021.09.11.21263428 — Posted: 2021-09-15
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
McKeigue, P. M., McAllister, D., Hutchinson, S. J., Robertson, C., Stockton, D., Colhoun, H. M.
10.1101/2021.09.12.21263448 — Posted: 2021-09-15 Discussion: Onsite
Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19
Piras, I. S., Huentelman, M., Walker, J., Arche, R., Glass, M., Vargas, D., Sue, L., Intorcia, A., Nelson, C., Suszczewicz, K., Borja, C., Desforges, M., Deture, M., Dicksond, D., Beach, T., Serrano, G.
10.1101/2021.09.12.21263291 — Posted: 2021-09-15
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Liu, Y., Zeng, Q., Deng, C., Li, M., Li, L., Liu, D., Mei, J., Mo, R., Zhou, Q., Liu, M., Peng, S., Wang, J., Zhang, H., Xiao, H.
10.1101/2021.09.12.21263373 — Posted: 2021-09-15
A comparative study of Bacterial culture isolates, site of infections and drug resistance pattern between COVID and non COVID patients admitted in a tertiary care hospital : A Pilot study
Haldar, A. K., Mukherjee, D. N., Seal, S., Dasgupta, H., Chakraborty, M.
10.1101/2021.09.12.21263386 — Posted: 2021-09-15
Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications in Australia
Enticott, J., Gill, J., Bacon, S., Lavoie, K. L., Epstein, D., Dawadi, S., Teede, H., Boyle, J.
10.1101/2021.09.12.21263158 — Posted: 2021-09-15
'Like brushing teeth' - Implementation experiences with opt-in, at-home screening for SARS-CoV-2 among schoolchildren in Germany
Wachinger, J., Schirmer, M., Taeuber, N., McMahon, S. A., Denkinger, C. M.
10.1101/2021.09.13.21263486 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).